Bearish Options Activity in Teva Pharma (TEVA) Targets Downside in Shares Into Year End, Ahead of Earnings on 8/3 -Susquehanna

Susquehanna options strategist Alison Edwards notes bearish options activity in Teva Pharma (NYSE: TEVA), as opening investors bought 9,000 Dec 32.5 Puts for $2.75, while another opening investor bought 6,000 Dec 30 Puts for $1.61, both targeting downside in the shares into the end of the year.

You May Also Be Interested In

• Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
• Altria Group (MO) April weekly option implied volatility into quarter results
• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates